- Home
- TNGX vs MBI Comparison
TNGX vs MBI Comparison
Compare TNGX & MBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- MBI
- Stock Information
- Founded
- TNGX 2014
- MBI 1973
- Country
- TNGX United States
- MBI United States
- Employees
- TNGX N/A
- MBI N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- MBI Property-Casualty Insurers
- Sector
- TNGX Health Care
- MBI Finance
- Exchange
- TNGX Nasdaq
- MBI Nasdaq
- Market Cap
- TNGX 317.4M
- MBI 311.3M
- IPO Year
- TNGX N/A
- MBI 1987
- Fundamental
- Price
- TNGX $3.35
- MBI $6.90
- Analyst Decision
- TNGX Strong Buy
- MBI Buy
- Analyst Count
- TNGX 8
- MBI 2
- Target Price
- TNGX $13.14
- MBI $6.75
- AVG Volume (30 Days)
- TNGX 757.1K
- MBI 447.4K
- Earning Date
- TNGX 03-17-2025
- MBI 02-26-2025
- Dividend Yield
- TNGX N/A
- MBI N/A
- EPS Growth
- TNGX N/A
- MBI N/A
- EPS
- TNGX N/A
- MBI N/A
- Revenue
- TNGX $43,383,000.00
- MBI N/A
- Revenue This Year
- TNGX $27.73
- MBI N/A
- Revenue Next Year
- TNGX N/A
- MBI N/A
- P/E Ratio
- TNGX N/A
- MBI N/A
- Revenue Growth
- TNGX 15.67
- MBI N/A
- 52 Week Low
- TNGX $2.59
- MBI $3.22
- 52 Week High
- TNGX $12.89
- MBI $7.27
- Technical
- Relative Strength Index (RSI)
- TNGX 58.01
- MBI 60.72
- Support Level
- TNGX $2.82
- MBI $5.90
- Resistance Level
- TNGX $3.20
- MBI $6.16
- Average True Range (ATR)
- TNGX 0.20
- MBI 0.33
- MACD
- TNGX 0.05
- MBI 0.10
- Stochastic Oscillator
- TNGX 97.40
- MBI 75.00
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.
About MBI MBIA Inc.
MBIA Inc provides financial guaranty insurance for municipal bonds and asset-backed securities in the United States and internationally. It offers an unconditional guarantee to repay the principal and interest on these securities if the issuer defaults. MBIA insures bonds sold in the primary and secondary markets, as well as those held in unit investment trusts and by mutual funds. It operates in three segments: the United States public finance insurance, corporate, and international & structured finance insurance. U.S. public finance insurance portfolio is managed through National Public Finance Guarantee Corporation. International & structured finance insurance business is managed through MBIA Insurance Corporation and its subsidiary.